Association of genomic loci from a cardiovascular gene SNP array with fibrinogen levels in European Americans and African-Americans from six cohort studies: the Candidate Gene Association Resource (CARe)

作者:Wassel Christina L; Lange Leslie A; Keating Brendan J; Taylor Kira C; Johnson Andrew D; Palmer Cameron; Ho Lindsey A; Smith Nicholas L; Lange Ethan M; Li Yun; Yang Qiong; Delaney Joseph A; Tang Weihong; Tofler Geoffrey; Redline Susan; Taylor Herman A Jr; Wilson James G; Tracy Russell P; Jacobs David R Jr; Folsom Aaron R; Green David; O'Donnell Christopher J; Reiner Alexander P*
来源:Blood, 2011, 117(1): 268-275.
DOI:10.1182/blood-2010-06-289546

摘要

Several common genomic loci, involving various immunity-and metabolism-related genes, have been associated with plasma fibrinogen in European Americans (EAs). The genetic determinants of fibrinogen in African Americans (AAs) are poorly characterized. Using a vascular gene-centric array in 23 634 EA and 6657 AA participants from 6 studies comprising the Candidate Gene Association Resource project, we examined the association of 47 539 common and lower frequency variants with fibrinogen concentration. We identified a rare Pro265Leu variant in FGB (rs6054) associated with lower fibrinogen. Common fibrinogen gene single nucleotide polymorphisms (FGB rs1800787 and FGG rs2066861) significantly associated with fibrinogen in EAs were prevalent in AAs and showed consistent associations. Several fibrinogen locus single nucleotide polymorphism associated with lower fibrinogen were exclusive to AAs; these include a newly reported association with FGA rs10050257. For IL6R, IL1RN, and NLRP3 inflammatory gene loci, associations with fibrinogen were concordant between EAs and AAs, but not at other loci (CPS1, PCCB, and SCL22A5-IRF1). The association of FGG rs2066861 with fibrinogen differed according to assay type used to measure fibrinogen. Further characterization of common and lower-frequency genetic variants that contribute to interpopulation differences in fibrinogen phenotype may help refine our understanding of the contribution of hemostasis and inflammation to atherothrombotic risk. (Blood. 2011;117(1):268-275)